Wolverine Trading, LLC Horizon Therapeutics Public LTD CO Put Options Transaction History

Wolverine Trading, LLC

$97.8 Billion
Q1 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $1.88 Million - $1.99 Million	-17,500 Reduced 87.06%	2,600 $284,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $1.25 Million - $2.29 Million	20,100 New	20,100 $2.29 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $873,400 - $1.28 Million	-11,000 Reduced 51.64%	10,300 $850,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $613,582 - $779,651	-7,100 Reduced 25.0%	21,300 $2.25 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $2.1 Million - $2.55 Million	21,300 Added 300.0%	28,400 $3.08 Million

Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $211,393 - $253,851	-2,300 Reduced 24.47%	7,100 $780,000
Q2 2021 Aug 06, 2021	SELL	$86.24 - $95.92 $1.13 Million - $1.26 Million	-13,100 Reduced 58.22%	9,400 $892,000
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $1.06 Million - $1.4 Million	-14,700 Reduced 39.52%	22,500 $1.96 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $582,900 - $734,193	8,700 Added 30.53%	37,200 $2.69 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $806,358 - $1.17 Million	14,600 Added 105.04%	28,500 $2.23 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $6,040 - $11,396	-200 Reduced 1.42%	13,900 $768,000
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $119,376 - $185,088	-4,800 Reduced 25.4%	14,100 $414,000
Q4 2019 Feb 12, 2020	SELL	$25.43 - $36.67 $22,887 - $33,003	-900 Reduced 4.55%	18,900 $681,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $535,900 - $651,701	-23,300 Reduced 54.06%	19,800 $545,000
Q2 2019 Aug 20, 2019	BUY	$22.81 - $28.48 $983,111 - $1.23 Million	43,100 New	43,100 $1.04 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account